Human Pathology
Volume 39, Issue 8 , Pages 1229-1233 , August 2008

Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activity

  • Alfred King-Yin Lam, MBBS, PhD, MD, FRCPA

      Affiliations

    • Discipline of Pathology, Griffith Medical School, Medicine and Oral Health Centre, Gold Coast Campus, Gold Coast, Queensland 4222, Australia
    • Corresponding Author InformationCorresponding author. Griffith Medical School, Gold Coast Campus, Gold Coast QLD 4222 Australia.
    • These authors contributed equally to the work.
    • ,
  • Said Saleh, BSc, PhD

      Affiliations

    • Discipline of Surgery (School of Medicine) and North Queensland Centre for Cancer Research (Australian Institute of Tropical Medicine), James Cook University, Townsville, Queensland 4811, Australia
    • These authors contributed equally to the work.
    • ,
  • Robert Anthony Smith, BSc, PhD

      Affiliations

    • Discipline of Pathology, Griffith Medical School, Medicine and Oral Health Centre, Gold Coast Campus, Gold Coast, Queensland 4222, Australia
    • ,
  • Yik-Hong Ho, MBBS, MD, FRACS

      Affiliations

    • Discipline of Surgery (School of Medicine) and North Queensland Centre for Cancer Research (Australian Institute of Tropical Medicine), James Cook University, Townsville, Queensland 4811, Australia

Received 14 October 2007 ,Revised 13 December 2007 ,Accepted 3 January 2008.

References 

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin. 2005;55:74–108
  2. Alvarado MD, Jensen EH, Yeatman TJ. The potential role of gene expression in the management of primary and metastatic colorectal cancer. Cancer Control. 2006;13:27–31
  3. Zaffaroni N, Pennati M, Folini M. Validation of telomerase and survivin as anticancer therapeutic targets using ribozymes and small-interfering RNAs. Methods Mol Biol. 2007;361:239–263
  4. Shay JW, Wright WE. Hallmarks of telomeres in aging research. J Pathol. 2007;211:114–123
  5. Nugent CI, Lundblad V. The telomerase reverse transcriptase: components and regulation. Genes Dev. 1998;12:1073–1085
  6. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011–2015
  7. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer. 1997;33:787–791
  8. Saleh S, Lam A, Ho YH. PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer. Pathology. 2008;40:25–30
  9. Johnson ME, Howerth EW. Survivin: a bifunctional inhibitor of apoptosis protein. Vet Pathol. 2004;41:599–607
  10. Li F, Brattain MG. Role of the survivin gene in pathophysiology. Am J Pathol. 2006;169:1–10
  11. Sah NK, Khan Z, Khan GJ, Bisen PS. Structural, functional and therapeutic biology of survivin. Cancer Lett. 2006;244:167–171
  12. Li F, Ling X. Survivin study: an update of “what is the next wave?”. J Cell Physiol. 2006;208:476–486
  13. Gerlach U, Kayser G, Walch A, et al. Centrosome-, chromosomal-passenger– and cell-cycle–associated mRNAs are differentially regulated in the development of sporadic colorectal cancer. J Pathol. 2006;208:462–472
  14. Lassmann S, Schuster I, Walch A, et al. STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation. J Clin Pathol. 2007;60:173–179
  15. Endoh T, Tsuji N, Asanuma K, Yagihashi A, Watanabe N. Survivin enhances telomerase activity via up-regulation of specificity protein 1– and c-Myc–mediated human telomerase reverse transcriptase gene transcription. Exp Cell Res. 2005;305:300–311
  16. Cao J, Chen XP, Li WL, et al. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition. World J Gastroenterol. 2007;13:1018–1026
  17. Khor TO, Gul YA, Ithnin H, Seow HF. A comparative study of the expression of Wnt-1, WISP-1, survivin and cyclin-D1 in colorectal carcinoma. Int J Colorectal Dis. 2006;21:291–300
  18. Okon K, Demczuk S, Klimkowska A, et al. Correlation of microsatellite status, proliferation, apoptotic and selected immunohistochemical markers in colorectal carcinoma studied with tissue microarray. Pol J Pathol. 2006;57:105–111
  19. Tan HY, Liu J, Wu SM, Luo HS. Expression of a novel apoptosis inhibitor-survivin in colorectal carcinoma. World J Gastroenterol. 2005;11:4689–4692
  20. Ponnelle T, Chapusot C, Martin L, et al. Cellular localisation of survivin: impact on the prognosis in colorectal cancer. J Cancer Res Clin Oncol. 2005;131:504–510
  21. Abd El-Hameed A. Survivin expression in colorectal adenocarcinoma using tissue microarray. J Egypt Natl Canc Inst. 2005;17:42–50
  22. Lin LJ, Zheng CQ, Jin Y, Ma Y, Jiang WG, Ma T. Expression of survivin protein in human colorectal carcinogenesis. World J Gastroenterol. 2003;9:974–977
  23. Agui T, McConkey DJ, Tanigawa N. Comparative study of various biological parameters, including expression of survivin, between primary and metastatic human colonic adenocarcinomas. Anticancer Res. 2002;22:1769–1776
  24. Kawasaki H, Toyoda M, Shinohara H, et al. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer. 2001;91:2026–2032
  25. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 1998 Nov 15;58:5071–5074
  26. Sarela AI, Scott N, Ramsdale J, Markham AF, Guillou PJ. Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas. Ann Surg Oncol. 2001;8:305–310
  27. Sarela AI, Macadam RC, Farmery SM, Markham AF, Guillou PJ. Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut. 2000;46:645–650
  28. Chen WC, Liu Q, Fu JX, Kang SY. Expression of survivin and its significance in colorectal cancer. World J Gastroenterol. 2004;10:2886–2889
  29. Hamilton SR, Vogelstein B, Kudo S, et al. Carcinoma of the colon and rectum. In:  Hamilton SR,  Aaltonen LA editor. In: WHO classification of tumours: pathology and genetics of tumours of digestive system. Lyon (France): IARC press; 2000;p. 105–119
  30. In:  Greene FL,  Page DL,  Fleming ID, et al. editor. AJCC cancer staging manual. 6th ed.. Berlin: Springer-Verlag; 2002;p. 113–119
  31. Megliorino R, Shi FD, Peng XX, et al. Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection. Cancer Detect Prev. 2005;29:241–248

☆ The project was supported by a grant from the Queensland Cancer Fund.

PII: S0046-8177(08)00008-7

doi: 10.1016/j.humpath.2008.01.001

Human Pathology
Volume 39, Issue 8 , Pages 1229-1233 , August 2008

Article Tools

* Image Usage & Resolution